fbpx

Research Study Opportunity

Abstract Title: Hereditary testing for breast and ovarian cancer in female veterans

Washington State University College of Nursing PhD student is conducting a dissertation research study regarding breast cancer patients and their experience with Hereditary Breast and Ovarian Cancer (HBOC) genetic screening within the Veteran’s Administration Health system.

Clinical Relevance: Breast cancer is the leading type of diagnosed cancer in the female veteran population. Women with breast cancer and at risk for HBOC mutation, genetic testing is recommended. Patients with HBOC mutation face an increased lifetime risk for both breast and ovarian cancers. Research is well-documented for civilian women with breast cancer and their experience with receiving HBOC testing. Female veterans have a notably higher risk of obesity, depression, post-traumatic stress syndrome than civilian women. There is a need for female veteran-focused research given the differences between non-veteran and veteran populations.

Study Purpose: This is a study to explore the experience of female veterans with breast cancer, who have had hereditary breast and ovarian cancer (HBOC) genetic testing. By conducting this research project, we hope to learn how female veterans with breast cancer describe the oncology care they receive in the VA system and specifically, their experience of receiving hereditary genetic testing for breast and ovarian cancer.

To Qualify you must: 

  • Be a female military veteran at least 18 years of age.
  • Have a diagnosis of breast cancer
  • Have accessed HBOC testing within the last 5 years.
  • Be receiving care from the Veteran’s Administration Medical Centers
  • Be English speaking and physically capable to participate.

What will I be asked to do if I am in this study? 

If you take part in the study, you will be asked to answer questions about breast cancer and genetic testing from your perspective as a female veteran. You will also be asked about how your life has been affected by this diagnosis and choice to have HBOC testing. The interview will be digitally recorded over the Zoom web-based platform. The data for this study will be kept confidential to the extent allowed by federal and state law.

This study has been certified as exempt by the Institutional Review Board for Washington State University. If you have questions about this study or the information in this form, please contact the Co-PI of this study Ms. Laura Sherburne at (360) 713-3980 or email: laura.sherburne@wsu.edu. Principal investigator Dr. Linda Eddy can be reached at 360-546-9625 or email: leddy@wsu.edu.

If you are interested in being a part of this research, please contact the Co-PI of this study Ms. Laura Sherburne at (360) 713-3980 or email: laura.sherburne@wsu.edu. Principal investigator Dr. Linda Eddy can be reached at 360-546-9625 or email: leddy@wsu.edu.